Anne S Hellkamp

Summary

Affiliation: Duke University Medical Center
Country: USA

Publications

  1. ncbi request reprint Treatment crossovers did not affect randomized treatment comparisons in the Mode Selection Trial (MOST)
    Anne S Hellkamp
    Duke Clinical Research Institute, Durham, North Carolina, USA
    J Am Coll Cardiol 47:2260-6. 2006
  2. doi request reprint Mortality benefits from implantable cardioverter-defibrillator therapy are not restricted to patients with remote myocardial infarction: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)
    Jonathan P Piccini
    Division of Cardiology, Duke University Medical Center, Durham, North Carolina 27710, USA
    Heart Rhythm 8:393-400. 2011
  3. doi request reprint Influenza vaccination of household contacts of newborns: a hospital-based strategy to increase vaccination rates
    Emmanuel B Walter
    Duke Clinical Vaccine Unit and Primary Care Research Consortium, Duke University Medical Center, Durham, NC 27704, USA
    Infect Control Hosp Epidemiol 31:1070-3. 2010
  4. ncbi request reprint Comparing classifications of death in the Mode Selection Trial: agreement and disagreement among site investigators and a clinical events committee
    John L Petersen
    Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27710, USA
    Contemp Clin Trials 27:260-8. 2006
  5. doi request reprint Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention o
    Manesh R Patel
    Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, USA
    J Am Coll Cardiol 61:651-8. 2013
  6. doi request reprint End of study transition from study drug to open-label vitamin K antagonist therapy: the ROCKET AF experience
    Kenneth W Mahaffey
    Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27705, USA
    Circ Cardiovasc Qual Outcomes 6:470-8. 2013
  7. pmc Trends in use of implantable cardioverter-defibrillator therapy among patients hospitalized for heart failure: have the previously observed sex and racial disparities changed over time?
    Sana M Al-Khatib
    MHS, Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC 27715, USA
    Circulation 125:1094-101. 2012
  8. doi request reprint Implantable cardioverter defibrillator therapy in patients with prior coronary revascularization in the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)
    Sana M Al-Khatib
    Duke Clinical Research Institute, Durham, North Carolina 27705, USA
    J Cardiovasc Electrophysiol 19:1059-65. 2008
  9. ncbi request reprint Optimal duration of eptifibatide infusion in percutaneous coronary intervention (an ESPRIT substudy)
    Abdallah G Rebeiz
    Duke Clinical Research Institute, Durham, North Carolina, USA
    Am J Cardiol 94:926-9. 2004
  10. ncbi request reprint Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction
    Michael O Sweeney
    Cardiac Arrhythmia Service, Brigham and Women s Hospital and Harvard Medical School, 75 Francis St, Boston, Mass 02115, USA
    Circulation 107:2932-7. 2003

Detail Information

Publications25

  1. ncbi request reprint Treatment crossovers did not affect randomized treatment comparisons in the Mode Selection Trial (MOST)
    Anne S Hellkamp
    Duke Clinical Research Institute, Durham, North Carolina, USA
    J Am Coll Cardiol 47:2260-6. 2006
    ..We evaluated the impact of treatment crossovers on study results in the Mode Selection Trial (MOST)...
  2. doi request reprint Mortality benefits from implantable cardioverter-defibrillator therapy are not restricted to patients with remote myocardial infarction: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)
    Jonathan P Piccini
    Division of Cardiology, Duke University Medical Center, Durham, North Carolina 27710, USA
    Heart Rhythm 8:393-400. 2011
    ....
  3. doi request reprint Influenza vaccination of household contacts of newborns: a hospital-based strategy to increase vaccination rates
    Emmanuel B Walter
    Duke Clinical Vaccine Unit and Primary Care Research Consortium, Duke University Medical Center, Durham, NC 27704, USA
    Infect Control Hosp Epidemiol 31:1070-3. 2010
    ..7% were vaccinated through the program, as were 25.7% of fathers. A hospital-based program provided opportunities for vaccination of household contacts of newborns, thereby facilitating better adherence to national vaccination guidelines...
  4. ncbi request reprint Comparing classifications of death in the Mode Selection Trial: agreement and disagreement among site investigators and a clinical events committee
    John L Petersen
    Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27710, USA
    Contemp Clin Trials 27:260-8. 2006
    ..These findings support continued use of CECs for endpoint adjudication in clinical trials...
  5. doi request reprint Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention o
    Manesh R Patel
    Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, USA
    J Am Coll Cardiol 61:651-8. 2013
    ..The purpose of this study was to understand the possible risk of discontinuation in the context of clinical care...
  6. doi request reprint End of study transition from study drug to open-label vitamin K antagonist therapy: the ROCKET AF experience
    Kenneth W Mahaffey
    Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27705, USA
    Circ Cardiovasc Qual Outcomes 6:470-8. 2013
    ..To evaluate the previously reported excess of thromboembolic events during the 30 days after the end of study (EOS) visit when participants transitioned from blinded therapy to open-label vitamin K antagonist...
  7. pmc Trends in use of implantable cardioverter-defibrillator therapy among patients hospitalized for heart failure: have the previously observed sex and racial disparities changed over time?
    Sana M Al-Khatib
    MHS, Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC 27715, USA
    Circulation 125:1094-101. 2012
    ..The degree to which the overall use of ICD therapy and disparities in use have changed is unclear...
  8. doi request reprint Implantable cardioverter defibrillator therapy in patients with prior coronary revascularization in the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)
    Sana M Al-Khatib
    Duke Clinical Research Institute, Durham, North Carolina 27705, USA
    J Cardiovasc Electrophysiol 19:1059-65. 2008
    ....
  9. ncbi request reprint Optimal duration of eptifibatide infusion in percutaneous coronary intervention (an ESPRIT substudy)
    Abdallah G Rebeiz
    Duke Clinical Research Institute, Durham, North Carolina, USA
    Am J Cardiol 94:926-9. 2004
    ....
  10. ncbi request reprint Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction
    Michael O Sweeney
    Cardiac Arrhythmia Service, Brigham and Women s Hospital and Harvard Medical School, 75 Francis St, Boston, Mass 02115, USA
    Circulation 107:2932-7. 2003
    ..The effect of pacing-induced ventricular desynchronization in patients with normal baseline QRSd is unknown...
  11. ncbi request reprint Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST)
    Taya V Glotzer
    Division of Electrophysiology, Hackensack University Medical Center, Hackensack, NJ, USA
    Circulation 107:1614-9. 2003
    ..The purpose of the study was to correlate atrial high rate events (AHREs) detected by pacemaker diagnostics with clinical outcomes...
  12. ncbi request reprint Complications arising after implantation of DDD pacemakers: the MOST experience
    Kenneth A Ellenbogen
    Division of Cardiology, Medical College of Virginia, PO Box 980053, Richmond, VA 23298 0053, USA
    Am J Cardiol 92:740-1. 2003
    ..This information may serve as a benchmark when comparing complication rates for dual-chamber pacemaker implantation with those for biventricular pacemaker implantation...
  13. pmc Prognostic importance of defibrillator shocks in patients with heart failure
    Jeanne E Poole
    Division of Cardiology, University of Washington School of Medicine, 1959 NE Pacific St, Box 356422, Seattle, WA 98195 6422, USA
    N Engl J Med 359:1009-17. 2008
    ..e., prevention of a first life-threatening arrhythmic event) may later receive therapeutic shocks from the ICD. Information about long-term prognosis after ICD therapy in such patients is limited...
  14. pmc Outcome in African Americans and other minorities in the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)
    Judith E Mitchell
    State University of New York Downstate Medical Center, Brooklyn, NY 11203, USA
    Am Heart J 155:501-6. 2008
    ..The purpose of this report is to describe the outcomes in African Americans (AAs) and other minorities...
  15. ncbi request reprint Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE Trial
    Mihai Gheorghiade
    Division of Cardiology, Northwestern University, Feinberg School of Medicine, 201 E Huron Street, Chicago, IL 60611, USA
    Arch Intern Med 167:1998-2005. 2007
    ..To our knowledge, the association of hyponatremia with outcomes has not been evaluated in the context of in-hospital clinical course including central hemodynamics and changes in serum sodium level...
  16. ncbi request reprint Where patients with mild to moderate heart failure die: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)
    Brian Olshansky
    Department of Internal Medicine, University of Iowa Hospitals, 4426A JCP, 200 Hawkins Dr, Iowa City, IA 52242, USA
    Am Heart J 153:1089-94. 2007
    ..In the SCD-HeFT, mortality of patients with CHF was assessed after randomization to an implantable cardioverter/defibrillator (ICD), amiodarone, or placebo. The aim of this study was to evaluate the location of deaths in SCD-HeFT...
  17. ncbi request reprint Risk of thromboembolism in heart failure: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)
    Ronald S Freudenberger
    Department of Medicine, Robert Wood Johnson Medical School, Suite 6100, 125 Paterson St, New Brunswick, NJ 08903, USA
    Circulation 115:2637-41. 2007
    ..In the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT), 2521 patients with moderate heart failure were randomized to receive amiodarone, implanted cardioverter-defibrillators (ICDs), or placebo...
  18. ncbi request reprint Role of amiodarone or implantable cardioverter/defibrillator in patients with atrial fibrillation and heart failure
    Steven N Singh
    Department of Veterans Affairs Medical Center, Washington, DC 20422, USA
    Am Heart J 152:974.e7-11. 2006
    ..The aim of the study was to determine the role of amiodarone or implantable cardioverter/defibrillator (ICD) in patients with AF and heart failure...
  19. ncbi request reprint Predictors of stroke in patients paced for sick sinus syndrome
    Arnold J Greenspon
    Division of Cardiology, Jefferson Medical College and Thomas Jefferson University Hospital, Philadelphia, Pennsylvania 19107, USA
    J Am Coll Cardiol 43:1617-22. 2004
    ..This study was an analysis of factors associated with stroke in a population of patients paced for sinus node dysfunction in a large prospective clinical trial (Mode Selection Trial [MOST])...
  20. ncbi request reprint Heart failure during cardiac pacing
    Michael O Sweeney
    Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
    Circulation 113:2082-8. 2006
    ..The adverse effects of ventricular desynchronization may explain the association of RVA pacing with an increased risk of heart failure hospitalization (HFH) in clinical trials...
  21. ncbi request reprint High incidence of pacemaker syndrome in patients with sinus node dysfunction treated with ventricular-based pacing in the Mode Selection Trial (MOST)
    Mark S Link
    Tufts New England Medical Center, Tufts University School of Medicine, Boston, Massachusetts 02111, USA
    J Am Coll Cardiol 43:2066-71. 2004
    ..We evaluated the incidence, predictors, and treatment of pacemaker syndrome in patients with sinus node dysfunction treated with ventricular-based (VVIR) pacing in the Mode Selection Trial (MOST)...
  22. ncbi request reprint The association of the heart failure score with mortality and heart failure hospitalizations in elderly patients: insights from the Mode Selection Trial (MOST)
    Eldrin F Lewis
    Cardiovascular Division, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
    Am Heart J 151:699-705. 2006
    ..This trend risks masking the severity and prevalence of HF as hospitalization for HF may decrease...
  23. ncbi request reprint Association of prolonged QRS duration with death in a clinical trial of pacemaker therapy for sinus node dysfunction
    Michael O Sweeney
    Cardiac Arrhythmia Service, Brigham and Women s Hospital, 75 Francis St, Boston, MA 02115, USA
    Circulation 111:2418-23. 2005
    ..The relationship of baseline QRSd to death and heart failure hospitalization in patients with sinus node dysfunction who require pacemaker therapy is unknown...
  24. ncbi request reprint Heart failure hospitalization is more common in pacemaker patients with sinus node dysfunction and a prolonged paced QRS duration
    Himanshu H Shukla
    University of Missouri Columbia, Columbia, Missouri, USA
    Heart Rhythm 2:245-51. 2005
    ..The purpose of this study was to determine whether a prolonged paced QRS duration increases the risk of cardiac dysfunction...
  25. ncbi request reprint Ventricular pacing or dual-chamber pacing for sinus-node dysfunction
    Gervasio A Lamas
    Division of Cardiology, Mount Sinai Medical Center, and the University of Miami School of Medicine, Miami Beach, Fla, USA
    N Engl J Med 346:1854-62. 2002
    ..However, it is unknown which type of pacing results in the better outcome...